Antimicrobial Wound Gel for Surgical Site Complications

N/A

Waitlist Available

Led By Giles Scuderi

Research Sponsored by Northwell Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks after index procedure

Awards & highlights

No Placebo-Only Group

Summary

This trial will study whether a new wound treatment can reduce surgical site complications and improve post-operative treatment outcomes.

Who is the study for?

This trial is for adults over 18 who are scheduled for primary hip or knee replacement surgery and can consent to participate. They must be able to follow the study's procedures throughout its duration. People with allergies to any study products, mental impairments preventing proper consent, or those considered vulnerable under specific federal regulations cannot join.

What is being tested?

The trial is testing SurgX Antimicrobial Wound Gel against standard wound care in patients undergoing hip or knee replacements. The goal is to see if SurgX reduces complications and improves outcomes by targeting bacteria at the surgical site.

What are the potential side effects?

While not explicitly listed, potential side effects may include allergic reactions to ingredients in SurgX gel or skin irritation at the application site. Standard care side effects depend on the typical treatments used post-surgery.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 12 weeks of the index procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 12 weeks of the index procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 12 weeks of the index procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Surgical site complication

Secondary study objectives

Wound images

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Treatment GroupExperimental Treatment1 Intervention

The treatment group will receive SurgX™ Antimicrobial Wound Gel™ applied over incision after closure and then re-applied at first dressing change on day of discharge in addition to standard of care.

Group II: Control GroupExperimental Treatment1 Intervention

The control group will receive standard of care.

Do I qualify?Apply below to find out